Delivery Order SPE2DB24D8002-SPE2DB24FJMUU
Award Date
8/23/24
Potential Completion Date
8/26/24
Potential Value
$8.5K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, identified as SPE2DB24D8002|SPE2DB24FJNAG, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The $17,696.27 firm fixed-price contract is for the delivery of STELARA 90 MG/ML SYRINGEML, a prescription medication. This award is a delivery order under Dakota Drug, Inc.'s existing Indefinite Delivery Contract (IDC) SPE2DB24D8001 with the DLA Troop...
This federal contract award, identified as SPE2DB24D8001|SPE2DB25FKZBM, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $11,352.56 firm fixed-price delivery order is for the provision of STELARA 90 MG/ML SYRINGEML, a pharmaceutical product, to support U.S. Armed Forces medical operations. Dakota Drug, Inc. holds a single-award Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, as part of the DLA...
This federal contract award, with ID SPE2DX15D8001|SPE2DX24FBQKX, was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The $11,091.23 firm fixed-price delivery order is for the supply of STELARA 90 MG/ML SYRINGEML pharmaceutical products. Dakota Drug, Inc. holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, as part of the DLA Troop Support Medical's...
This federal contract award, with ID SPE2DB24D8002|SPE2DB25FJNCE, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $10,144.61 firm fixed-price delivery order is for the supply of STELARA 90 MG/ML SYRINGEML, a pharmaceutical product. The award is associated with Dakota Drug, Inc.'s existing $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001. This IDC, which is part of the DLA Troop...
This federal contract award, SPE2DB24D8002|SPE2DB25FJNGC, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $12,239.65 firm fixed-price delivery order is for STELARA 90 MG/ML SYRINGEML, a pharmaceutical product. This award is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) SPE2DB24D8001 with the DLA Troop Support Medical division, valued at $999,999,999.00, which allows the company to provide a...
This federal contract award, identified as SPE2DB24D8001|SPE2DB25FKZLG, was issued by the Defense Logistics Agency (DLA) to the prime contractor Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of STELARA 90 MG/ML SYRINGEML, a pharmaceutical product, to support U.S. Armed Forces medical operations. The contract has a ceiling value of $8,114.16 and a period of performance through March 28, 2025. It is a Firm Fixed Price Delivery Order contract,...
This federal contract award, identified as SPE2DX15D8001|SPE2DX23FBQQM, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $10,062.39 delivery order contract is for the supply of STELARA 90 MG/ML SYRINGEML, a pharmaceutical product, with a performance period through April 17, 2023. The award is not associated with a set-aside program and is part of Dakota Drug, Inc.'s larger...
This federal contract award, identified as SPE2DX15D8002|SPE2DX24F2UV0, was made by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The $12,512.79 firm fixed-price delivery order is for the provision of STELARA 90 MG/ML SYRINGEML, a pharmaceutical product, with a performance period extending to February 7, 2024. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA,...
This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $8,445.88, is for the delivery of STELARA 90 MG/ML SYRINGEML, a pharmaceutical product, with a performance period ending on March 18, 2025. The contract is a delivery order issued under Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, which has a total potential value of...
This federal contract award, with ID SPE2DB24D8001|SPE2DB25FKZKH, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $9,440.85, is a delivery order for the pharmaceutical product STELARA 90 MG/ML SYRINGE. It is a firm fixed-price contract with a period of performance extending through March 20, 2025. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at...